Danli Zhou[Author] - Search Results

Year	Number of Results
2014	1
2015	2
2016	1
2017	2
2019	3
2020	1
2021	1
2022	2
2023	4
2024	1

1

Light-Induced Protein Degradation with Photocaged PROTACs.

Xue G, Wang K, Zhou D, Zhong H, Pan Z. Xue G, et al. Among authors: zhou d. J Am Chem Soc. 2019 Nov 20;141(46):18370-18374. doi: 10.1021/jacs.9b06422. Epub 2019 Oct 3. J Am Chem Soc. 2019. PMID: 31566962

2

Protein degradation through covalent inhibitor-based PROTACs.

Xue G , Chen J , Liu L , Zhou D , Zuo Y , Fu T , Pan Z . Xue G , et al. Among authors: zhou d. Chem Commun (Camb). 2020 Feb 4;56(10):1521-1524. doi: 10.1039/c9cc08238g. Chem Commun (Camb). 2020. PMID: 31922153

3

Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity.

Zhou D, Zuo Y, Pan Z. Zhou D, et al. J Med Chem. 2023 Apr 13;66(7):4979-4998. doi: 10.1021/acs.jmedchem.2c02078. Epub 2023 Mar 23. J Med Chem. 2023. PMID: 36959108

4

Clinical and Genetic Analysis of a Patient With Coexisting 17a-Hydroxylase/17,20-Lyase Deficiency and Moyamoya Disease.

Huang J, Zhou D, Dong N, Ding C, Liu Y, Li F. Huang J, et al. Among authors: zhou d. Front Genet. 2022 Aug 30;13:845016. doi: 10.3389/fgene.2022.845016. eCollection 2022. Front Genet. 2022. PMID: 36110215 Free PMC article.

5

Discovery of 2,5-diaminopyrimidine derivatives as the first series of selective monomeric degraders of B-lymphoid tyrosine kinase.

Fu T, Zuo Y, Xue G, Zhou D, Pan Z. Fu T, et al. Among authors: zhou d. Eur J Med Chem. 2023 Aug 5;256:115460. doi: 10.1016/j.ejmech.2023.115460. Epub 2023 May 5. Eur J Med Chem. 2023. PMID: 37163946

6

Cx32 inhibits the autophagic effect of Nur77 in SH-SY5Y cells and rat brain with ischemic stroke.

Ping F, Zhang C, Wang X, Wang Y, Zhou D, Hu J, Chen Y, Ling J, Zhou J. Ping F, et al. Among authors: zhou d. Aging (Albany NY). 2021 Sep 22;13(18):22188-22207. doi: 10.18632/aging.203526. Epub 2021 Sep 22. Aging (Albany NY). 2021. PMID: 34551394 Free PMC article.

7

A lifetime economic research of universal HLA-B*58:01 genotyping or febuxostat initiation therapy in Chinese gout patients with mild to moderate chronic kidney disease.

Hong Y, Chen X, Li Z, Zhang X, Zhou C, Wang Y, Wang G, Wu W, Zhou D, Feng Li H. Hong Y, et al. Among authors: zhou d. Pharmacogenet Genomics. 2023 Feb 1;33(2):24-34. doi: 10.1097/FPC.0000000000000488. Epub 2022 Dec 9. Pharmacogenet Genomics. 2023. PMID: 36729770

8

Preferential, synergistic sorption and reduction of Cr(VI) from chromium-rhodamine B mixed wastewater by magnetic porous biochar derived from wasted Myriophyllum aquaticum biomass.

Zhang D, Zhou D, Lu L, Zhang M, Lü T, Huang J, Zhao H, Zhou J, Rinklebe J. Zhang D, et al. Among authors: zhou d. Environ Pollut. 2023 Jun 15;327:121593. doi: 10.1016/j.envpol.2023.121593. Epub 2023 Apr 6. Environ Pollut. 2023. PMID: 37030599

9

Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain.

Zhou D, Zhang S, Hu L, Gu YF, Cai Y, Wu D, Liu WT, Jiang CY, Kong X, Zhang GQ. Zhou D, et al. J Neuroinflammation. 2019 Apr 11;16(1):83. doi: 10.1186/s12974-019-1476-6. J Neuroinflammation. 2019. PMID: 30975172 Free PMC article.

10

A DNA arithmetic logic unit for implementing data backtracking operations.

Zhong W , Tang W , Tan Y , Fan J , Huang Q , Zhou D , Hong W , Liu Y . Zhong W , et al. Among authors: zhou d. Chem Commun (Camb). 2019 Jan 15;55(6):842-845. doi: 10.1039/c8cc08441f. Chem Commun (Camb). 2019. PMID: 30575824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

15 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year